Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells

Liquid biopsy of tumor through isolation of circulating tumor cells (CTCs) allows non-invasive, repetitive, and systemic sampling of disease. Although detecting and enumerating CTCs is of prognostic significance in metastatic cancer, it is conceivable that performing molecular and functional characterization on CTCs will reveal unprecedented insight into the pathogenic mechanisms driving lethal disease. Nanomaterial-embedded cancer diagnostic platforms, i.e., NanoVelcro CTC Assays represent a unique rare-cell sorting method that enables detection isolation, and characterization of CTCs in peripheral blood, providing an opportunity to noninvasively monitor disease progression in individual cancer patients. Over the past decade, a series of NanoVelcro CTC Assays has been demonstrated for exploring the full potential of CTCs as a clinical biomarker, including CTC enumeration, phenotyping, genotyping and expression profiling. In this review article, the authors will briefly introduce the development of three generations of NanoVelcro CTC Assays, and highlight the clinical applications of each generation for various types of solid cancers, including prostate cancer, pancreatic cancer, lung cancer, and melanoma.

[1]  L. Chin,et al.  Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. , 2004, Nucleic acids research.

[2]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[3]  Hsian-Rong Tseng,et al.  Microfluidic image cytometry for quantitative single-cell profiling of human pluripotent stem cells in chemically defined conditions. , 2010, Lab on a chip.

[4]  Anil K Sood,et al.  A novel platform for detection of CK+ and CK- CTCs. , 2011, Cancer discovery.

[5]  A. Chambers,et al.  Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[6]  Hong Wu,et al.  A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. , 2010, Cancer research.

[7]  Qinghua Feng,et al.  An automated high-throughput counting method for screening circulating tumor cells in peripheral blood. , 2013, Analytical chemistry.

[8]  Swee Jin Tan,et al.  Microdevice for the isolation and enumeration of cancer cells from blood , 2009, Biomedical microdevices.

[9]  S. Tavaré,et al.  Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma , 2015, Nature Genetics.

[10]  R. Pethig,et al.  ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. , 2012, Biomicrofluidics.

[11]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[12]  Peter Kuhn,et al.  A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Planchard,et al.  A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas , 2011, British Journal of Cancer.

[14]  Mark M Davis,et al.  Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device , 2009, Proceedings of the National Academy of Sciences.

[15]  Behrad Vahidi,et al.  Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell , 2014, PloS one.

[16]  T. Graeber,et al.  Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer , 2016, British Journal of Cancer.

[17]  Dino Di Carlo,et al.  Automated cellular sample preparation using a Centrifuge-on-a-Chip. , 2011, Lab on a chip.

[18]  T. Graeber,et al.  Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. , 2016, The Journal of molecular diagnostics : JMD.

[19]  Sabine Riethdorf,et al.  Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells , 2010, Annals of the New York Academy of Sciences.

[20]  Daniel T Chiu,et al.  Sensitive and high-throughput isolation of rare cells from peripheral blood with ensemble-decision aliquot ranking. , 2012, Angewandte Chemie.

[21]  Chwee Teck Lim,et al.  Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. , 2010, Biosensors & bioelectronics.

[22]  Nada Jabado,et al.  Circulating tumor cells: detection, molecular profiling and future prospects , 2007, Expert review of proteomics.

[23]  Tony Tran,et al.  Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay. , 2013, Translational oncology.

[24]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[25]  Shuang Hou,et al.  Nanostructure Embedded Microchips for Detection, Isolation, and Characterization of Circulating Tumor Cells , 2014, Accounts of chemical research.

[26]  P. Jänne,et al.  A new device for rapid isolation by size and characterization of rare circulating tumor cells. , 2011, Anticancer research.

[27]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[28]  Zachary R. Gagnon,et al.  Cellular dielectrophoresis: Applications to the characterization, manipulation, separation and patterning of cells , 2011, Electrophoresis.

[29]  Aviv Regev,et al.  Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer , 2014, Nature Biotechnology.

[30]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[31]  A. Syvänen,et al.  Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNA. , 2003, Nucleic acids research.

[32]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[33]  D. Paul,et al.  Enhancing surface interactions with colon cancer cells on a transferrin-conjugated 3D nanostructured substrate. , 2012, Small.

[34]  Kam Y. J. Zhang,et al.  Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.

[35]  Joshua M. Kunken,et al.  Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers , 2012, Physical biology.

[36]  Xiaochun Xu,et al.  NanoVelcro Chip for CTC enumeration in prostate cancer patients. , 2013, Methods.

[37]  Xiaohong Fang,et al.  High‐Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber‐Embedded Microchip for Whole Exome Sequencing , 2013, Advanced materials.

[38]  Sridhar Ramaswamy,et al.  A microfluidic device for label-free, physical capture of circulating tumor cell-clusters , 2015, Nature Methods.

[39]  Siyang Zheng,et al.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. , 2007, Journal of chromatography. A.

[40]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[41]  H. Scher,et al.  Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[42]  J. Nieva,et al.  Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. , 2009, Archives of pathology & laboratory medicine.

[43]  Boran Cheng,et al.  Electrospun TiO2 Nanofiber‐Based Cell Capture Assay for Detecting Circulating Tumor Cells from Colorectal and Gastric Cancer Patients , 2012, Advanced materials.

[44]  Channing J Der,et al.  KRAS: feeding pancreatic cancer proliferation. , 2014, Trends in biochemical sciences.

[45]  Adam Olshen,et al.  Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. , 2013, Cancer research.

[46]  Jason P. Gleghorn,et al.  Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. , 2010, Lab on a chip.

[47]  Klaus Pantel,et al.  [The circulating tumor cells: liquid biopsy of cancer]. , 2014, Klinicheskaia laboratornaia diagnostika.

[48]  Sridhar Ramaswamy,et al.  Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.

[49]  David Issadore,et al.  Miniaturized nuclear magnetic resonance platform for detection and profiling of circulating tumor cells. , 2014, Lab on a chip.

[50]  Jean Salamero,et al.  Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays , 2010, Proceedings of the National Academy of Sciences.

[51]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[52]  Adam H Mepham,et al.  Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations. , 2015, Angewandte Chemie.

[53]  Yi-Kuen Lee,et al.  Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. , 2011, Angewandte Chemie.

[54]  David J Beebe,et al.  The VerIFAST: an integrated method for cell isolation and extracellular/intracellular staining. , 2013, Lab on a chip.

[55]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[56]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[57]  Shutao Wang,et al.  Designing fractal nanostructured biointerfaces for biomedical applications. , 2014, Chemphyschem : a European journal of chemical physics and physical chemistry.

[58]  Daniel F. Hayes,et al.  Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets , 2013, Nature nanotechnology.

[59]  H. Tseng,et al.  3D bioelectronic interface: capturing circulating tumor cells onto conducting polymer-based micro/nanorod arrays with chemical and topographical control. , 2014, Small.

[60]  Hyeun Joong Yoon,et al.  Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis , 2014, ACS nano.

[61]  Wei Liu,et al.  Biocompatible TiO2 nanoparticle-based cell immunoassay for circulating tumor cells capture and identification from cancer patients , 2013, Biomedical Microdevices.

[62]  Xiaohong Fang,et al.  Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. , 2010, Accounts of chemical research.

[63]  Faraz Hach,et al.  Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.

[64]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[65]  J. Chalmers,et al.  Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells , 2009, Biotechnology and bioengineering.

[66]  Rajan P Kulkarni,et al.  High efficiency vortex trapping of circulating tumor cells. , 2015, Biomicrofluidics.

[67]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[68]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[69]  Wen-Hwa Lee,et al.  Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection , 2016, PloS one.

[70]  Sridhar Ramaswamy,et al.  RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance , 2015, Science.

[71]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[72]  Shuang Hou,et al.  Programming Thermoresponsiveness of NanoVelcro Substrates Enables Effective Purification of Circulating Tumor Cells in Lung Cancer Patients , 2014, ACS nano.

[73]  W. Isaacs,et al.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. , 2014, The New England journal of medicine.

[74]  Sridhar Ramaswamy,et al.  RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.

[75]  Kinam Kim,et al.  Full surface embedding of gold clusters on silicon nanowires for efficient capture and photothermal therapy of circulating tumor cells. , 2012, Nano letters.

[76]  Hsian-Rong Tseng,et al.  Functionalized Conducting Polymer Nanodots for Enhanced Cell Capturing: The Synergistic Effect of Capture Agents and Nanostructures , 2011, Advanced materials.

[77]  Utkan Demirci,et al.  Nanostructured substrates for isolation of circulating tumor cells. , 2013, Nano today.

[78]  X. Xie,et al.  Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.

[79]  M. Middleton,et al.  Circulating melanoma cells and survival in metastatic melanoma. , 2011, International journal of oncology.

[80]  Paul I. Okagbare,et al.  Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. , 2008, Journal of the American Chemical Society.

[81]  H. Tseng,et al.  Capture and Stimulated Release of Circulating Tumor Cells on Polymer‐Grafted Silicon Nanostructures , 2013, Advanced materials.

[82]  Yu Cao,et al.  Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing , 2014, Science.

[83]  Yi Liu,et al.  Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail. , 2016, Small.

[84]  Chin Chun Ooi,et al.  Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. , 2014, Lab on a chip.

[85]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[86]  Weian Zhao,et al.  Bioinspired multivalent DNA network for capture and release of cells , 2012, Proceedings of the National Academy of Sciences.

[87]  Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. , 2013, Angewandte Chemie.

[88]  Klaus Pantel,et al.  Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.

[89]  Xiaoyu Jia,et al.  Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. , 2009, The Lancet. Oncology.

[90]  Mehmet Toner,et al.  Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells , 2013, Science Translational Medicine.

[91]  Andrew M. K. Brown,et al.  Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.

[92]  Hong Wu,et al.  Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. , 2009, Angewandte Chemie.

[93]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[94]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[95]  J. Nam,et al.  Nanoparticle-functionalized polymer platform for controlling metastatic cancer cell adhesion, shape, and motility. , 2011, ACS nano.

[96]  Seungpyo Hong,et al.  Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. , 2011, Angewandte Chemie.

[97]  Shana O Kelley,et al.  Beyond the Capture of Circulating Tumor Cells: Next-Generation Devices and Materials. , 2016, Angewandte Chemie.

[98]  Shuang Hou,et al.  Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases , 2015, Cancer.

[99]  Shuang Hou,et al.  A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer , 2015, Oncotarget.